Agility achieves human-use WDA authorisation for UK facilities
17 / 09 / 2018
Logistics firm Agility has received a Wholesaler Distribution Authorisation for Medicines for Human Use (WDAh) from the UK Medicines Healthcare & Regulatory Agency (MHRA).
The certification authorises warehousing and cross-dock of a wide range of pharmaceuticals, including finished products and active pharmaceutical ingredients (API) under ambient and cold chain conditions.
The certification covers the Agility-managed pharma storage facility at London’s Heathrow Airport and a second pharma competence centre in Bristol.
The WDA(H) allows Agility to provide a number of additional services, including pick-and-pack operations for the distribution of stored products to hospitals, pharmacies and other distributors, the re-packing into active and passive shipping configurations, and the distribution of clinical trial materials.
Colm McAlinden, managing director for Agility Area North West, said: “With this new certification, we are able to expand our Life Science service offerings in the UK and operate on behalf of our customers, particularly virtual wholesalers, brokers and importers. The certification also provides Agility with flexibility for post-Brexit import and export regulations.”
Read more pharma logistics news
Click here for a free digital subscription